Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin in PIK3CA mutated colon cancer
NCT02467582Phase 3Terminated
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- Jun 2016
- Primary completion
- Sep 2023
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
Phase 3, randomised, double-blind trial of aspirin in colon cancer, sponsored by Swiss Group for Clinical Cancer Research. Started Jun 2016; status: terminated.
02
Drugs
aspirin
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT02467582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02467582.